Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation

Haematologica - Tập 101 Số 8 - Trang 926-931 - 2016
Alberto Álvarez‐Larrán1, Arturo Pereira2, Paola Guglielmelli3,4, Juan Carlos Hernández‐Boluda5, Eduardo Arellano‐Rodrigo2, Francisca Ferrer‐Marín6, A. Samah7, Martin Grießhammer8, Ana Kerguelen9, Björn Andréasson10, Carmen Burgaleta11, Jiřı́ Schwarz12, Valentín García‐Gutiérrez13, Rosa Ayala14, Pere Barba15, María Teresa Gómez‐Casares16, Chiara Paoli3,4, Beatrice Drexler17, Sonja Zweegman18, Mary Frances McMullin19, Jessica Samuelsson20, C. Harrison7, Francisco Cervantes21, Vannucchi Am3,4, C. Besses1
1Hematology Department, Hospital del Mar, IMIM, UAB, Barcelona, Spain
2Hematotherapy and Hemostasis Department, Hospital Clínic, Barcelona, Spain
3AOU Careggi, and Department of Experimental and Clinical Medicine, University of Florence, Italy
4Center for Research and Innovation of MPN (CRIMM)
5Hematology Department, Hospital Clínico, Valencia, Spain
6Hematology and Medical Oncology Department, Hospital Morales Messeguer, IMIB-Arrixaca, UCAM, Murcia, Spain
7Haematology Department, Guys’ and St Thomas’ NHS Foundation Trust, London, UK
8Hematology, Oncology & Palliative Care, Johannes Wesling Academic Medical Center, University of Hannover Teaching Hospital, Germany
9Hematology Department, Hospital La Paz, Madrid, Spain
10Hematology Section, Uddevalla Hospital, NU Hospital Group, Sweden
11Hematology Department, Hospital Príncipe de Asturias, Alcalá de Henares, Spain
12Institute of Hematology & Blood Transfusion, Prague, Czech Republic
13Hematology Department, Hospital Ramón y Cajal, Madrid, Spain
14Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
15Hematology Department, Hospital Vall d'Hebron, Barcelona, Spain
16Hematology Department, Hospital Dr. Negrín, Las Palmas de Gran Canaria, Spain
17Division of Hematology, University Hospital Basel, Switzerland
18Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands
19Centre for Cancer Research and Cell Biology, Queen's University, Belfast, UK
20Department of Clinical Science and Education, Karolinska Institute, South Hospital, Stockholm, Sweden
21Hematology Department, Hospital Clínic, IDIBAPS, Barcelona, Spain

Tóm tắt

Từ khóa


Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Haematologica

Tập 101 Số 8

926-931

Thông tin tác giả